US Patent Issued to CELLICON LAB on Sept. 29 for "Antimicrobial peptide with excellent microbial cytoplasm elution effect" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,266, issued on Sept. 29, was assigned to CELLICON LAB INC. (Daejeon, South Korea).

"Antimicrobial peptide with excellent microbial cytoplasm elution effect" was invented by Min Gyu Soung (Daejeon, South Korea), Bo Kyung Park (Daejeon, South Korea), Won Suk Choi (Daejeon, South Korea), Young Pil Jeong (Daejeon, South Korea), Ji Hyun Park (Sejong-si, South Korea) and Jae Hoo Park (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an antimicrobial peptide, a derivative thereof, or a fragment thereof; a polynucleotide encoding the antimicrobial peptide, a derivative thereof, or a fragment thereof; and...